Atrioventricular Node Ablation for Atrial Fibrillation in a Patient With EVOQUE Tricuspid Valve: A First Reported
Padmapriya Muthu1, Hema Vemulapalli1, Poojan Prajapati1
1Division of Cardiovascular Diseases, Mayo Clinic Hospital, Phoenix, Arizona, USA.
Introduction:
Atrial fibrillation (AF) is the most common arrhythmia, and atrioventricular (AV) node ablation with pacemaker implantation is a therapeutic option for refractory cases. However, AV node ablation in patients with bioprosthetic tricuspid valves poses technical challenges.
Methods:
An 84-year-old male with an EVOQUE transcatheter tricuspid valve replacement underwent AV node ablation (AVNA) under intracardiac echocardiography (ICE) guidance.
Results:
Successful AV block was achieved with precise catheter positioning, improving the patient's symptoms and ventricular rate control.
Conclusion:
This case demonstrates the feasibility of AVNA in patients with tricuspid bioprostheses, demonstrating feasibility with ICE guidance.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Electrophysiology of Normal Cardiac Rhythm


